AC Immune (ACIU) Set to Announce Earnings on Friday

AC Immune (NASDAQ:ACIU) is set to announce its earnings results on Friday, April 26th.

AC Immune (NASDAQ:ACIU) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. The company had revenue of $16.71 million for the quarter, compared to the consensus estimate of $16.36 million. On average, analysts expect AC Immune to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

AC Immune Trading Down 0.4 %

Shares of NASDAQ:ACIU opened at $2.37 on Thursday. The stock’s 50-day moving average price is $3.12 and its 200-day moving average price is $3.34. AC Immune has a 12-month low of $1.78 and a 12-month high of $5.14. The stock has a market capitalization of $234.39 million, a P/E ratio of -3.34 and a beta of 1.00.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and issued a $16.00 target price on shares of AC Immune in a research note on Friday, March 15th.

AC Immune Company Profile

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.